Urocortin II gene is highly expressed in mouse skin and skeletal muscle tissues: localization, basal expression in corticotropin-releasing factor receptor (CRFR) 1- and CRFR2-null mice, and regulation by glucocorticoids.

Peptides encoded by the Urocortin (Ucn) II gene, also known as stresscopin-related peptide, were recently identified as new members of the corticotropin-releasing factor (CRF) family. Ucn II is a specific ligand for the type 2 CRF receptor (CRFR). We have demonstrated the peripheral distribution of mouse Ucn (mUcn) II transcripts by using specific mUcn II ribonuclease protection assays, RT-PCR, Southern hybridization, and DNA sequencing. Although Ucn II mRNA is widely expressed in a variety of peripheral tissues, we found it to be most highly expressed in the skin and skeletal muscle tissues. Using a specific RIA for mUcn II, we detected Ucn II-like immunoreactivity (ir) in acid extracts of mouse brain, muscle, and skin. Immunohistochemical studies revealed Ucn II-like ir in both skin epidermis and adnexal structures and in the skeletal muscle myocytes. Ucn II mRNA and ir were also observed in neonatal skeletal muscle cultures in which Ucn II was localized to the myotube. We found a significant increase in Ucn II mRNA levels in the skin, but not in skeletal muscle, of both CRFR1- and CRFR2-null mice compared with their wild-type littermates. We showed that administration of dexamethasone to mice resulted in a decrease of Ucn II mRNA levels in the back skin region 12 h after ip injections. Removal of the adrenal gland significantly increased the levels of Ucn II mRNA in the skin, and the levels were reduced back to normal levels after corticosterone replacement. Further examination of the distribution and regulation of CRFR2 and its specific ligand Ucn II in the skin and skeletal muscle tissues may reveal the manner by which the CRFR2 pathway is involved in the physiological responses to stress in these tissues and in other pathophysiologies of the skin and muscle.

[1]  J. Vaughan,et al.  Glucocorticoids regulate the expression of the mouse urocortin II gene: a putative connection between the corticotropin-releasing factor receptor pathways. , 2003, Molecular endocrinology.

[2]  J. Vaughan,et al.  Urocortin III is expressed in pancreatic beta-cells and stimulates insulin and glucagon secretion. , 2003, Endocrinology.

[3]  T. Suda,et al.  Urocortin-related peptides increase interleukin-6 output via cyclic adenosine 5'-monophosphate-dependent pathways in A7r5 aortic smooth muscle cells. , 2003, Endocrinology.

[4]  B. Wiesner,et al.  Intracellular calcium measurements of single human skin cells after stimulation with corticotropin-releasing factor and urocortin using confocal laser scanning microscopy , 2003, Journal of Cell Science.

[5]  W. Scherbaum,et al.  Corticotropin-releasing hormone: An autocrine hormone that promotes lipogenesis in human sebocytes , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[6]  E. Aggelidou,et al.  Up-regulation of nitric oxide synthase and modulation of the guanylate cyclase activity by corticotropin-releasing hormone but not urocortin II or urocortin III in cultured human pregnant myometrial cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[7]  R. Hauger,et al.  The CRF peptide family and their receptors: yet more partners discovered. , 2002, Trends in pharmacological sciences.

[8]  A. Slominski,et al.  Alternative splicing of CRH‐R1 receptors in human and mouse skin: identification of new variants and their differential expression , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[9]  G. Coukos,et al.  Corticotropin-releasing hormone promotes blastocyst implantation and early maternal tolerance , 2001, Nature Immunology.

[10]  J. Mazurkiewicz,et al.  Cutaneous expression of corticotropin‐releasing hormone (CRH), urocortin, and CRH receptors , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[11]  C. Donaldson,et al.  Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[12]  A. Hsueh,et al.  Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor , 2001, Nature Medicine.

[13]  J. Vaughan,et al.  Urocortin II: A member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[14]  P. Sawchenko,et al.  Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse , 2000, The Journal of comparative neurology.

[15]  A. Slominski,et al.  Neuroendocrinology of the skin. , 2000, Endocrine reviews.

[16]  R. Paus,et al.  Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. , 2000, Physiological reviews.

[17]  K. Barron,et al.  Corticosterone delivery to the amygdala increases corticotropin-releasing factor mRNA in the central amygdaloid nucleus and anxiety-like behavior , 2000, Brain Research.

[18]  Susan E. Murray,et al.  Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2 , 2000, Nature Genetics.

[19]  O. Hermanson,et al.  Deletion of Crhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2 , 2000, Nature Genetics.

[20]  Paul E. Sawchenko,et al.  Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress , 2000, Nature Genetics.

[21]  A. Slominski,et al.  The skin produces urocortin. , 2000, The Journal of clinical endocrinology and metabolism.

[22]  G. Koob,et al.  A role for corticotropin releasing factor and urocortin in behavioral responses to stressors , 1999, Brain Research.

[23]  R. Paus,et al.  Cutaneous Expression of CRH and CRH‐R: Is There a “Skin Stress Response System?” , 1999, Annals of the New York Academy of Sciences.

[24]  W. Vale,et al.  Corticotropin Releasing Factor Receptors and Their Ligand Family , 1999, Annals of the New York Academy of Sciences.

[25]  F. Petraglia,et al.  Urocortin stimulates placental adrenocorticotropin and prostaglandin release and myometrial contractility in vitro. , 1999, The Journal of clinical endocrinology and metabolism.

[26]  T. Theoharides,et al.  Potent mast cell degranulation and vascular permeability triggered by urocortin through activation of corticotropin-releasing hormone receptors. , 1999, The Journal of pharmacology and experimental therapeutics.

[27]  F. Holsboer,et al.  Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1 , 1998, Nature Genetics.

[28]  G. Koob,et al.  Corticotropin Releasing Factor Receptor 1–Deficient Mice Display Decreased Anxiety, Impaired Stress Response, and Aberrant Neuroendocrine Development , 1998, Neuron.

[29]  B. Brar,et al.  Cardiotrophin-1 induces heat shock protein accumulation in cultured cardiac cells and protects them from stressful stimuli. , 1998, Journal of molecular and cellular cardiology.

[30]  R. Knight,et al.  Expression and protective effects of urocortin in cardiac myocytes , 1998, Neuropeptides.

[31]  R. Paus,et al.  Hair cycle-dependent expression of corticotropin-releasing factor (CRF) and CRF receptors in murine skin. , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[32]  L. Bilezikjian,et al.  Pituitary follistatin and inhibin subunit messenger ribonucleic acid levels are differentially regulated by local and hormonal factors. , 1996, Endocrinology.

[33]  W. Vale,et al.  Urocortin, a corticotropin-releasing factor-related mammalian peptide, inhibits edema due to thermal injury in rats. , 1996, European journal of pharmacology.

[34]  David Lovejoy,et al.  Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor , 1995, Nature.

[35]  E. De Souza,et al.  Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[36]  K. Yamada,et al.  Stress-induced activation of neuronal activity and corticotropin-releasing factor gene expression in the paraventricular nucleus is modulated by glucocorticoids in rats. , 1995, The Journal of clinical investigation.

[37]  G. Chrousos,et al.  The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. , 1995, The New England journal of medicine.

[38]  R. Cone,et al.  Identification of a novel murine receptor for corticotropin-releasing hormone expressed in the heart. , 1995, Molecular endocrinology.

[39]  C. Donaldson,et al.  Identification of a second corticotropin-releasing factor receptor gene and characterization of a cDNA expressed in heart. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[40]  M. Rosenfeld,et al.  A sauvagine/corticotropin-releasing factor receptor expressed in heart and skeletal muscle. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[41]  T. Lovenberg,et al.  Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[42]  C. Donaldson,et al.  Distribution of corticotropin-releasing factor receptor mRNA expression in the rat brain and pituitary. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[43]  K. Lewis,et al.  Expression cloning of a human corticotropin-releasing-factor receptor. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[44]  C. Nemeroff,et al.  Physiology and pharmacology of corticotropin-releasing factor. , 1991, Pharmacological reviews.

[45]  P. Sawchenko,et al.  Differential regulation of corticotropin-releasing factor mRNA in rat brain regions by glucocorticoids and stress , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[46]  S. Lightman,et al.  Stress responsiveness of hypothalamic corticotrophin-releasing factor and pituitary pro-opiomelanocortin mRNAs following high-dose glucocorticoid treatment and withdrawal in the rat. , 1990, The Journal of endocrinology.

[47]  J. Challis,et al.  Steroid, corticotrophin-releasing hormone, ACTH and prostaglandin interactions in the amnion and placenta of early pregnancy in man. , 1990, The Journal of endocrinology.

[48]  J. Vaughan,et al.  Characterization of melanin-concentrating hormone from rat hypothalamus. , 1989, Endocrinology.

[49]  L. Swanson,et al.  Differential steroid hormone and neural influences on peptide mRNA levels in CRH cells of the paraventricular nucleus: A hybridization histochemical study in the rat , 1989, The Journal of comparative neurology.

[50]  S. Matta,et al.  Regulation of the messenger ribonucleic acid for corticotropin-releasing factor in the paraventricular nucleus and other brain sites of the rat. , 1988, Endocrinology.

[51]  G. Fink,et al.  Effects of adrenalectomy and glucocorticoids on the peptides CRF‐41, AVP and oxytocin in rat hypophysial portal blood. , 1988, The Journal of physiology.

[52]  K. Kovács,et al.  Dexamethasone inhibits corticotropin-releasing factor gene expression in the rat paraventricular nucleus. , 1987, Neuroendocrinology.

[53]  W. Young,et al.  Quantitative in situ hybridization histochemistry reveals increased levels of corticotropin-releasing factor mRNA after adrenalectomy in rats , 1986, Neuroscience Letters.

[54]  R. Perry,et al.  Characterization of the multigene family encoding the mouse S16 ribosomal protein: strategy for distinguishing an expressed gene from its processed pseudogene counterparts by an analysis of total genomic DNA , 1985, Molecular and cellular biology.

[55]  H. Imura,et al.  Effects of adrenalectomy and dexamethasone administration on the level of prepro-corticotropin-releasing factor messenger ribonucleic acid (mRNA) in the hypothalamus and adrenocorticotropin/beta-lipotropin precursor mRNA in the pituitary in rats. , 1985, Endocrinology.

[56]  W. Vale,et al.  Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin , 1981 .

[57]  A. Blount,et al.  Urocortin messenger ribonucleic acid: tissue distribution in the rat and regulation in thymus by lipopolysaccharide and glucocorticoids. , 1999, Endocrinology.

[58]  R. Paus,et al.  Glucocorticoid effect on hair growth initiation: a reconsideration. , 1993, Skin pharmacology : the official journal of the Skin Pharmacology Society.

[59]  J. Vaughan,et al.  Detection and purification of inhibin using antisera generated against synthetic peptide fragments. , 1989, Methods in enzymology.

[60]  J. Mazurkiewicz,et al.  Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1998 by The Endocrine Society COMMENTS Characterization of Corticotropin-Releasing Hormone , 2022 .

[61]  S. Kawana,et al.  The FASEB Journal express article 10.1096/fj.01-0254-fje. Published online August 17, 2001. In situ expression of corticotropin-releasing hormone (CRH) and proopiomelanocortin (POMC) genes in human skin , 2022 .

[62]  G. Chrousos,et al.  Printed in U.S.A. Copyright © 1998 by The Endocrine Society Corticotropin-Releasing Hormone Induces Skin Mast Cell Degranulation and Increased Vascular Permeability, A Possible Explanation for Its Proinflammatory Effects* , 2022 .